FPAY Overview

VTI ETF Performance: The Vanguard Total Stock Market ETF (VTI) has increased by 1.06% over the past week and 17.62% year-to-date, despite a 1.07% decline on Thursday amid rising global tensions.

Investor Activity: VTI saw a net inflow of $38 million over the last five trading days, with an average trading volume of 4.08 million shares, indicating strong investor interest.

Analyst Consensus: VTI is rated as a Moderate Buy by analysts, with a price target of $379.46 suggesting a potential upside of 13.58%.

Top Holdings and Potential: The ETF's largest holdings include Nvidia, Microsoft, and Apple, while its top five stocks with the highest upside potential are FlexShopper, FibroBiologics, Biodesix, BioAtla, and Cibus.

VTI ETF Performance: The Vanguard Total Stock Market ETF (VTI) has increased by 2.07% over the past five days and 17.62% year-to-date, despite a slight decline of 0.07% on Wednesday.

Investor Activity: VTI saw a net inflow of $38 million over the last five trading days, with an average trading volume of 4.08 million shares.

Analyst Consensus: VTI is rated as a Moderate Buy by analysts, with a price target of $379.46 indicating a potential upside of 12.36%.

Top Holdings and Potential: The ETF's top holdings include Nvidia, Microsoft, and Apple, while it has identified several stocks with high upside potential and others with significant downside risks.

VTI ETF Performance: The Vanguard Total Stock Market ETF (VTI) has increased by 2.40% over the past week and 17.52% year-to-date, with a notable gain of 1.1% on Monday, coinciding with a record high for the Nasdaq Composite.

Investor Activity: VTI experienced a net inflow of $703 million over the last five trading days, indicating strong investor interest, with an average trading volume of 4.07 million shares.

Analyst Consensus and Price Target: VTI is rated as a Moderate Buy by analysts, with an average price target of $376.33, suggesting an upside potential of 11.53%.

Top Holdings and Potential: The ETF's largest holdings include Nvidia, Microsoft, and Apple, while its top five stocks with the highest upside potential are FlexShopper, FibroBiologics, Biodesix, BioAtla, and Cibus.

Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.

Exclusive Community: Joining Benzinga Pro connects traders with over 10,000 members, providing access to unique stories and insights from Benzinga reporters.

Earnings Performance: XP Inc.A reported quarterly earnings of $0.43 per share, matching estimates and showing an increase from $0.39 per share a year ago, while revenues of $786.31 million fell short of expectations by 5.8%.

Stock Outlook: The company's stock has risen approximately 48.2% since the start of the year, significantly outperforming the S&P 500's 9.7% gain, with a current Zacks Rank of #1 (Strong Buy) indicating positive future performance.

Future Earnings Estimates: Current consensus estimates predict EPS of $0.45 and revenues of $870.3 million for the next quarter, with a fiscal year estimate of $1.72 EPS on $3.4 billion in revenues.

Industry Context: XP Inc.A operates within the Financial - Miscellaneous Services sector, which ranks in the top 18% of Zacks industries, suggesting that industry trends could impact the stock's performance moving forward.

Astera Labs Financial Performance: Astera Labs, Inc. shares surged 17.3% in pre-market trading after reporting a record $191.9 million in revenue for Q2, a 20% increase from the previous quarter and a 150% year-over-year rise, along with optimistic third-quarter guidance.

Market Movements: Several stocks experienced significant pre-market trading fluctuations, with BiomX Inc. gaining 34.2% following a stake report by Morgan Stanley, while LifeMD, Inc. saw a decline of 28.8% due to disappointing financial results and weak guidance.